E1A tumor suppressor gene: TGEN began Phase I tests

Targeted Genetics Corp. (TGEN), Seattle,Wash. Product: E1A tumor suppressor gene, inhibitor of the HER-2/neu oncogene Indication: Breast and ovarian cancers Status: TGEN began Phase I tests of its inh...